×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞ·þÎñ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

ºãÈð GLP1R/GIPR/GCGR Èý°Ðµã¼¤¶¯¼Á»ñÅúÁÙ´² £¬ÓÃÓÚ³¬ÖØ»ò·ÊÅÖ | 1·ÖÖÓÒ©ÎÅËÙÀÀ

2024-12-06
|
»á¼ûÁ¿£º

΢ÐÅͼƬ_20241202165305.jpg

Ò½ÏßÒ©ÎÅ

1. 12ÔÂ6ÈÕ £¬CDE ¹ÙÍøÏÔʾ £¬ºãÈð1ÀàÐÂÒ© HRS-4729 ×¢ÉäÒºº£ÄÚÊ״λñÅúÁÙ´² £¬ÄâÓÃÓÚ³¬ÖØ»ò·ÊÅÖ¡£HRS-4729 ÊǺãÈð×ÔÖ÷Ñз¢µÄÏÂÒ»´ú³¦´ÙÒȵºËزúÆ· £¬Æ¾Ö¤ÏàÖúÆóÒµ¹ÙÍø¹ÜÏßÏÔʾ £¬ÕâÊÇÒ»¿î GLP1R/GIPR/GCGR Èý°Ðµã¼¤¶¯¼Á¡£

2. 12ÔÂ6ÈÕ £¬ÈðÆÕ³¿´´Ðû²¼CDEÅú×¼Á˺£ÄÚÊ׸ö¶àÐÑĿϸ°ûÌÇÄò²¡Ò©Æ·µÄÁÙ´²ÊÔÑé £¬ÓÃÓÚÖÎÁÆ1ÐÍÌÇÄò²¡¡£RGB-5088ÒȵºÏ¸°û×¢ÉäÒº¡£

3. 12ÔÂ5ÈÕ £¬CDE¹ÙÍø¹«Ê¾ £¬ÓÉ°¢Ë¹Àû¿µ£¨AstraZeneca£©É걨µÄAZD2936ºÍDS-8201aÁ½¿îÐÂҩͬʱ»ñµÃÁÙ´²ÊÔÑéĬʾÔÊÐí £¬Ë³Ó¦Ö¢Îª¾Ö²¿ÍíÆÚ»òתÒÆÐÔHER2±í´ïµ¨µÀ°©»¼ÕßµÄÒ»ÏßÖÎÁÆ¡£

4. 12ÔÂ5ÈÕ £¬ÔÿµÒ©ÒµÐû²¼Í¨¸æ £¬ÆäÈ«×Ê×Ó¹«Ë¾º¼ÖÝÌìÁúÒ©ÒµÓÚ¿ËÈÕ»ñµÃÃÀ¹úFDA¹ØÓÚÔÞ³ÉYKYY026×¢ÉäÒºÓÃÓÚÔ¤·À´ø×´ðåÕî¾ÙÐÐÁÙ´²ÊÔÑéµÄº¯¸æ¡£YKYY026ÊÇÔÿµÒ©Òµ×ÔÖ÷¿ª·¢µÄÒ»¿î±àÂëË®¶»-´ø×´ðåÕ¶¾ (VZV)gEÂѰ׿¹Ô­µÄmRNAÒßÃç £¬ÓÃÓÚÔ¤·À´ø×´ðåÕî¡£

ͶÈÚÒ©ÊÂ

1. ¿ËÈÕ £¬GSKÐû²¼ÓëÖØÇìÖÇ·ÉÉúÎïÖÆÆ·¹É·ÝÓÐÏÞ¹«Ë¾¸æ¿¢ÐÂЭÒé £¬½«Ë«·½µÄÕ½ÂÔÒßÃçÏàÖúÀ©Õ¹ÖÁ2034Äê¡£´Ë´ÎÏàÖúÉý¼¶ £¬²»µ«ÑÓÉìÁËGSK´ø×´ðåÕîÒßÃç¡°ÐÀ°²Á¢ÊÊ¡±£¨Shingrix£©µÄÍƹãÏÞÆÚ £¬»¹½«Ì½Ë÷ºôÎüµÀºÏ°û²¡¶¾£¨RSV£©ÒßÃç Arexvy ÔÚÖйúÊг¡µÄÉÌÒµ»¯Ç±Á¦¡£Æ¾Ö¤Ð­Òé £¬Ô¤¼Æ2024ÄêÖÁ2029Äêʱ´ú £¬ÖÇ·ÉÉúÎï²É¹º¡°ÐÀ°²Á¢ÊÊ¡±µÄ×ܼÛÖµ¿ÉÄܸߴï23ÒÚÓ¢°÷ £¬ÕÃÏÔÁËÏàÖúµÄÖ÷ÒªÐԺ͹æÄ£¡£

¿Æ¼¼Ò©ÑÐ

1. 12ÔÂ3ÈÕ £¬¹ú¼ÒÄÉÃ׿ÆѧÖÐÐÄÄô¹ã¾üÑо¿Ô±¡¢ÀîÒ»Ò¶Ñо¿Ô±µÈÔÚ Nature ×Ó¿¯ Nature Communications ÉϽÒÏþÁËÌâΪ£ºDual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine µÄÑо¿ÂÛÎÄ¡£¸ÃÑо¿Éè¼ÆÁËÒ»ÖÖ³ÌÐò»¯ÄÉÃ×ϵͳ £¬ÒÔË«ÖؾÀÕý¹ý±í´ïÆÏÌÑÌÇתÔËÂÑ°×1£¨GLUT1£©ºÍCD71µÄÒÈÏÙµ¼¹ÜÏÙ°©£¨PDAC£©Ï¸°ûºÍÒÈÏÙÐÇ״ϸ°û£¨PSC£©µÄ´úлÒì³£ £¬ÓÃÓÚÖ×ÁöÖÎÁÆ¡£

[1]Wu, B., Wang, Z., Liu, J. et al. Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. Nat Commun 15, 10526 (2024). https://doi.org/10.1038/s41467-024-54963-y

Ïà¹ØÐÂÎÅ
ºãÈðÒ½Ò©¿¨ÈðÀûÖéµ¥¿¹ÍŽáÁÆ·¨ÄâÄÉÈëÍ»ÆÆÐÔÖÎÁÆÆ·ÖÖØ­¡°ÃÀ¡±ÌìÐÂÒ©ÊÂ
2022-10-23
10ÔÂ23ÈÕ £¬ºãÈðÒ½Ò©Ðû²¼Í¨¸æ £¬¿¨ÈðÀûÖéµ¥¿¹ÁªÕýµ±Ã×ÌæÄáÒ»ÏßÖÎÁÆÖ×Áöϸ°ûPD-L1±í´ïÑôÐÔ£¨TPS¡Ý1%£©ÇÒ²»°éÓÐEGFR/ALK»ùÒòÒì³£µÄ¸´·¢ÐÔ»òתÒÆÐÔ·ÇСϸ°û·Î°©£¨NSCLC£©Ë³Ó¦Ö¢ÓÚ¿ËÈÕ±»Ò©ÉóÖÐÐÄ£¨CDE£©ÄâÄÉÈëÍ»ÆÆÐÔÖÎÁÆÆ·ÖÖ¹«Ê¾Ãûµ¥ £¬¹«Ê¾ÆÚ7ÈÕ¡£
ºãÈðÒ½Ò©Õë¶ÔHER2µÍ±í´ïÈéÏÙ°©ADCÁÆ·¨ÄâÄÉÈëÍ»ÆÆÐÔÖÎÁÆÆ·ÖÖØ­¡°ÃÀ¡±ÌìÐÂÒ©ÊÂ
2023-02-12
ºãÈðÒ½Ò©1ÀàÐÂÒ©×¢ÉäÓÃSHR-A1811Á½ÏîÁÙ´²ÊÔÑéÉêÇëÄâÄÉÈëÍ»ÆÆÐÔÖÎÁÆÆ·ÖÖ £¬»®·ÖÓÃÓÚ£ºÈ˱íƤÉú³¤Òò×ÓÊÜÌå2£¨HER2£©µÍ±í´ïµÄ¸´·¢»òתÒÆÐÔÈéÏÙ°© £¬ÒÔ¼°HER2ÑôÐԵĸ´·¢»òתÒÆÐÔÈéÏÙ°©»¼Õß¡£¹ûÕæ×ÊÁÏÏÔʾ £¬SHR-A1811ÊǺãÈðÒ½Ò©×ÔÖ÷Ñз¢µÄÒÔHER2Ϊ°ÐµãµÄ¿¹ÌåżÁªÒ©ÎADC£©¡£
ºãÈðÒ½Ò©¿¹PD-L1µ¥¿¹¡¸°¢µÃ±´Àûµ¥¿¹¡¹»ñÅúÉÏÊÐØ­¡°ÃÀ¡±ÌìÐÂÒ©ÊÂ
2023-03-03
3ÔÂ3ÈÕ £¬Öйú¹ú¼ÒÒ©¼à¾Ö£¨NMPA£©¹ÙÍø¹«Ê¾ £¬ºãÈðÒ½Ò©×ÔÖ÷Ñз¢µÄ¿¹PD-L1µ¥¿¹°¢µÃ±´Àûµ¥¿¹×¢ÉäÒºÒÑ»ñÅúÉÏÊС£Æ¾Ö¤ºãÈðÒ½Ò©ÔçÏÈÐÂÎÅ¸å £¬¸ÃÒ©±¾´Î»ñÅúµÄ˳Ӧ֢Ϊ£ºÍŽữÁÆÒ»ÏßÖÎÁÆÆÕ±éÆÚСϸ°û·Î°©£¨ES-SCLC£©¡£
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£ºk1ÌåÓý  918²©ÌìÌà ÒøºÓ¼¯ÍÅ198net  cq9µç×Ó  cq9µç×Ó  918²©ÌìÌà AG¿­·¢k8ÕæÈËÓéÀÖ  ¿­Ê±¹Ù·½  ÂÀÊϹó±ö»á  ca88¹ÙÍø  k1ÌåÓý  ok138Ì«Ñô¼¯ÍÅ  ÀÖÌìÌÃfun88  ×ðÁú¿­Ê±  yd2333Ôƶ¥µç×ÓÓÎÏ·